Cao Xianjiao, He Qingqing
The First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250011, People's Republic of China.
Department of Thyroid and Breast Surgery, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, Shandong 250031, People's Republic of China.
Cancer Manag Res. 2020 Feb 27;12:1457-1467. doi: 10.2147/CMAR.S243127. eCollection 2020.
Patients with breast cancer and breast cancer survivors are frequent users of botanicals and their bioactive phytochemicals. In China, active ingredients in like matrine (MT), oxymatrine (OMT), other alkaloids and Compound Kushen Injection (CKI) are extensively used for multiple malignant tumors. In vivo and in vitro studies have confirmed that these activities or injection have significant effects on relieving symptoms, alleviating side effects after chemotherapy and improving the quality of life of breast cancer patients, where there is evidence for efficacy. A large number of experimental studies have also revealed that they can inhibit the proliferation, invasion and migration of breast cancer cells according to different mechanisms. This provides promising valuable supportive therapies for prevention, treatment and postoperative recovery of breast cancer. Rigorous clinical research and experimental studies reflect integrative care as it is used in hospital is needed to responsibly move this field forward. This review summarizes an up to date knowledge of the available bioactive phytochemicals, their discovery, current clinical and experimental status.
乳腺癌患者及乳腺癌幸存者经常使用植物药及其具有生物活性的植物化学物质。在中国,苦参碱(MT)、氧化苦参碱(OMT)、其他生物碱以及复方苦参注射液(CKI)等中的活性成分被广泛用于多种恶性肿瘤。体内和体外研究证实,这些活性成分或注射液对缓解症状、减轻化疗后副作用以及提高乳腺癌患者的生活质量具有显著效果,且有疗效证据。大量实验研究还表明,它们可根据不同机制抑制乳腺癌细胞的增殖、侵袭和迁移。这为乳腺癌的预防、治疗及术后恢复提供了有前景的宝贵支持性疗法。严谨的临床研究和实验研究表明,需要在医院采用综合护理措施,以负责任地推动该领域向前发展。本综述总结了现有生物活性植物化学物质的最新知识、它们的发现、当前的临床和实验状况。